Emergent BioSolutions (EBS) Other financing activities (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Other financing activities of -$800000.0 for Q3 2025, down 214.29% quarter-over-quarter from $700000.0 in Q2 2025.
Emergent BioSolutions (EBS) Other financing activities (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Other financing activities history runs 16 years deep, the most recent figure standing at -$800000.0 for Q3 2025.
- In Q3 2025, Other financing activities changed N/A year-over-year to -$800000.0; the TTM figure through Mar 2026 stood at -$100000.0 (down 100.74% YoY), while the FY2024 annual figure was $13.4 million, changed N/A from the prior year.
- Other financing activities for Q3 2025 stood at -$800000.0, down from $700000.0 in the prior quarter.
- The five-year high for Other financing activities was $12.7 million in Q4 2024, with the low at -$3.0 million in Q4 2022.
- The 5-year median for Other financing activities is $1.0 million (2023), against an average of $2.1 million.
- The sharpest annual moves came in 2022 and 2025: Other financing activities tumbled 188.24% in 2022, then changed 0.0% in 2025.
- Emergent BioSolutions' Other financing activities stood at $3.4 million in 2021, then sank by 188.24% to -$3.0 million in 2022, then jumped by 56.67% to -$1.3 million in 2023, then soared by 1076.92% to $12.7 million in 2024, then tumbled by 106.3% to -$800000.0 in 2025.
- Business Quant data shows EBS's Other financing activities at -$800000.0 in Q3 2025, $700000.0 in Q2 2025, and $100000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 253.61 Mn | 112.71 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.40 Mn |
| Jun 30, 2026 | 1.40 Mn |
| Sep 30, 2025 | -800,000.00 |
| Sep 30, 2025 | -800,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 12.70 Mn |
| Dec 31, 2024 | 12.70 Mn |
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Sep 30, 2023 | -1.30 Mn |
| Sep 30, 2023 | -1.30 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 2.50 Mn |